Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
6,095,789
-
Shares change
-
-80,322
-
Total reported value, excl. options
-
$65,347,731
-
Value change
-
+$515,236
-
Put/Call ratio
-
1.07%
-
Number of buys
-
34
-
Number of sells
-
-28
-
Price
-
$10.72
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q3 2024
82 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q3 2024.
AVITA Medical, Inc. - Common Stock (RCEL) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,095,789 shares
of 26,475,256 outstanding shares and own 23.02% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1,860,519 shares), VANGUARD GROUP INC (1,417,672 shares), GEODE CAPITAL MANAGEMENT, LLC (594,436 shares), STATE STREET CORP (519,997 shares), ESSEX INVESTMENT MANAGEMENT CO LLC (231,094 shares), NORTHERN TRUST CORP (216,467 shares), AWM Investment Company, Inc. (98,173 shares), MORGAN STANLEY (97,413 shares), JANE STREET GROUP, LLC (89,395 shares), and GOLDMAN SACHS GROUP INC (85,317 shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.